PhillyPharma Archive: July, 2012

GSK's Witty: Sterner enforcement is a question that 'goes far beyond the drug industry'

Comment icon 0 Comments
Billion-dollar fines for inappropriate drug marketing are considered part of the cost of doing business for pharmaceutical companies, industry... Read more

Alzheimer's drug fails in late stage test

Comment icon 0 Comments
Because so many mental health mysteries remain unsolved - and difficult to define - pharmaceutical companies view the area with great hope... Read more

GlaxoSmithKline provides lab for drug testing at Summer Olympics

Comment icon 0 Comments
Being the United Kingdom's largest pharmaceutical company, GlaxoSmithKline is all in when it comes to the Summer Olympics, which open Friday... Read more

J&J legal crew stays busy; pharmacists wary of Walgreens-Express Scripts deal

Comment icon 0 Comments
We wrap up the week by mentioning several issues involving pharmaceuticals and pharmacies. Oh, and money and more money. First, a group of... Read more

With big money pending, J&J's Gorsky plays nice with FDA

Comment icon 0 Comments
To listen to Johnson & Johnson's new chief executive officer Alex Gorsky Tuesday during the quarterly conference call with Wall Street... Read more

Johnson & Johnson reports drop in revenue, profit for second quarter

Comment icon 0 Comments
Health-care giant Johnson & Johnson reported Tuesday that second-quarter overall revenue fell and profit dropped nearly 50 percent over... Read more

GlaxoSmithKline gets Human Genome Sciences for $3 billion

Comment icon 0 Comments
GlaxoSmithKline said Monday it has a deal to buy Human Genome Sciences for about $3 billion, which is $400 million more than the London-based... Read more

Q&A with AmerisourceBergen CEO Steven Collis

Comment icon 0 Comments
AmerisourceBergen is the largest company by revenue with headquarters in Pennsylvania. Don’t worry, if you didn’t know. You’re... Read more